Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech Market Cap: 6.872M for Dec. 30, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.517B |
| Harvard Bioscience, Inc. | 29.33M |
| Intensity Therapeutics, Inc. | 22.56M |
| NovaBay Pharmaceuticals, Inc. | 781.27M |
| Palatin Technologies, Inc. | 13.47M |
Market Cap Related Metrics
| Price | 3.32 |
| Earnings Yield | -1.32K% |